Hero C

Meet Donors Like You

Meeting in the Middle
For Jane Trinh, MD’02, HS’02-’06, and her husband, Peter Grossi, MD’02, HS’02- ’08, Duke University School of Medicine was the place where they met in the middle.
An Integrative Health Pioneer
Norman C. Shealy, BSM’56, MD’56, HS’56-’57, PhD, wakes up at 5 a.m. every weekday for a workout before heading into the clinic. “A light day is an hour of exercise,” he says. “Ninety minutes is more typical.”
Deep Roots at Duke
When Robert Yowell, MD’61, HS’64-’69, entered the Duke University School of Medicine in 1957, he was, by a pretty fair margin, the youngest student at the school.
A True Gift
Jeanne Caldwell didn’t have Alzheimer’s disease, yet she knew firsthand the devastation it can cause. For 11 years she cared for her mother who had the disease. After her mother’s death in 2015, Caldwell was determined to do what she could to make sure other families did not have to endure the hardships of caring for a loved one with Alzheimer’s.
Treats From the Heart
As a high school freshman, Elianna started baking “cookies” for their horses, using ingredients like oat flour and molasses. “It's so nice to give them something you put effort into, something from the heart," she says.
$1M Gift Will Establish ADHD Center for Girls and Women
An anonymous family’s generosity will enable Duke University School of Medicine to establish one of the nation’s only programs dedicated specifically to helping girls and women with Attention Deficit Hyperactivity Disorder (ADHD).
Duke to Launch Phase 1 Trial of COVID-19 Treatment
The Duke Human Vaccine Institute (DHVI) has been given approval to launch a Phase 1 clinical trial of one of its most promising antibody treatments for COVID-19. This would be a temporary treatment until a vaccine is developed. The DHVI also is developing a pan-coronavirus vaccine that would combat future iterations of COVID-19 and similar viruses, and also researching if saliva can be used as an accurate indicator of COVID-19 infection.
New Vaccine Blocks COVID-19 and Variants, Plus Other Coronaviruses
A potential new vaccine developed by members of the Duke Human Vaccine Institute has proven effective in protecting monkeys and mice from a variety of coronavirus infections — including SARS-CoV-2 as well as the original SARS-CoV-1 and related bat coronaviruses that could potentially cause the next pandemic. The findings were published in the journal Nature.
A Family Legacy for Duke Cancer
Ever since Duke Cancer Institute helped Meg Lindenberger survive breast cancer more than a decade ago, she and her husband, Bill, have been faithful supporters.
A Constant Presence
In 2016, Duke employee Brandy Chieco was a new mom with a three-month-old baby boy when her own mom, Brenda Brooks, was diagnosed with synovial sarcoma, which tends to arise in the joints.

Inspirational Stories

Explore and Learn the Impact of our Philanthropy.

DUMC